Sorafenib

CHEMBL1336 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
464.8 g/mol
LogP
4.1
Phase
4

This multi-targeted oral kinase inhibitor blocks several proteins that cancer cells use to grow new blood vessels and divide, effectively cutting off tumor blood supply and directly slowing cancer cell proliferation. It is approved for liver, kidney, and thyroid cancers and is studied in bladder and breast cancers.

分子量

464.8000 g/mol

LogP

4.10

TPSA

92.40 Ų

Lipinski 五规则

符合

治疗领域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1

InChI

InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)

Molecular Formula

C21H16ClF3N4O3

HBD / HBA

3 / 7

可旋转键数

5

重原子数

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

This multi-targeted oral kinase inhibitor blocks several proteins that cancer cells use to grow new blood vessels and divide, effectively cutting off tumor blood supply and directly slowing cancer cell proliferation. It is approved for liver, kidney, and thyroid cancers and is studied in bladder and breast cancers.

Yes, Sorafenib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1336. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 216239. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.